Chintan V Dave
Overview
Explore the profile of Chintan V Dave including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
544
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Myers C, Perskaudas R, Reddy V, Dave C, Keilp J, King A, et al.
Front Psychiatry
. 2025 Feb;
15:1492332.
PMID: 39949497
Background: Learning from feedback - adapting behavior based on reinforcing and punishing outcomes - has been implicated in numerous psychiatric disorders, including substance misuse, post-traumatic stress disorder, and depression; an...
2.
Liu X, Graham L, Jing B, Dave C, Li Y, Kurella Tamura M, et al.
J Am Geriatr Soc
. 2025 Jan;
PMID: 39750005
Background: Deprescribing antihypertensives is of growing interest in geriatric medicine, yet the impact on functional status is unknown. We emulated a target trial of deprescribing antihypertensive medications compared with continued...
3.
Odden M, Graham L, Liu X, Dave C, Lee S, Li Y, et al.
JAMA Netw Open
. 2024 Nov;
7(11):e2446851.
PMID: 39585693
Importance: The practice of deprescribing antihypertensive medications is common among long-term care residents, yet the effect on cardiovascular outcomes is unclear. Objective: To compare the incidence of hospitalization for myocardial...
4.
Wang E, Patorno E, Khosrow-Khavar F, Crystal S, Dave C
Diabetologia
. 2024 Nov;
68(1):94-104.
PMID: 39514094
Aims/hypothesis: The aim of this study was to investigate racial and ethnic disparities in the use of sodium-glucose cotransporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor antagonists (GLP-1RAs) among older...
5.
Yalamanchili P, Lee L, Bushnell G, Mannion M, Dave C, Horton D
Arthritis Rheumatol
. 2024 Oct;
PMID: 39435602
Objective: The objective of this study is to describe recent trends in disease-modifying antirheumatic drug (DMARD) use for children with juvenile idiopathic arthritis (JIA) in the United States. Methods: We...
6.
Patel S, Zhu K, Dave C, Ghajar M, Zhang Y, Saraiya B, et al.
Eur Urol Oncol
. 2024 Sep;
PMID: 39343637
Background And Objective: Gonadotropin-releasing hormone (GnRH) antagonists and agonists are cornerstone treatments in prostate cancer. However, evidence regarding the comparative cardiovascular safety of these drugs from clinical trials is inconclusive....
7.
Jing B, Liu X, Graham L, Dave C, Li Y, Fung K, et al.
JAMA Intern Med
. 2024 Sep;
184(11):1347-1355.
PMID: 39312220
Importance: Antihypertensive medication deprescribing is common among nursing home residents, yet its association with cognitive decline remains uncertain. Objective: To investigate the association of deprescribing antihypertensive medication with changes in...
8.
Myers C, Dave C, Chesin M, Marx B, St Hill L, Reddy V, et al.
Behav Res Ther
. 2024 Sep;
183:104637.
PMID: 39306938
Objective: Develop and evaluate a treatment matching algorithm to predict differential treatment response to Mindfulness-Based Cognitive Therapy for suicide prevention (MBCT-S) versus enhanced treatment-as-usual (eTAU). Methods: Analyses used data from...
9.
Odden M, Dave C
J Am Geriatr Soc
. 2024 Aug;
72(11):3291-3293.
PMID: 39210687
No abstract available.
10.